Nurix
The Director, Quality Assurance leads GMP quality assurance for small molecule CMC programs and serves as the primary quality interface with CDMO partners. This role ensures the quality and timely supply of clinical materials, maintains inspection readiness, and builds and mentors the QA team through late-stage development toward commercialization. The position reports to the Senior Vice President, Quality, and operates both strategically and hands-on in a dynamic clinical-stage environment.
Headquarters
Brisbane, California, United States
Company Size
201-500 employees
Founded
2012
Nurix Therapeutics is a clinical-stage biopharmaceutical company developing medicines that harness targeted protein degradation to treat cancer and autoimmune diseases. Using a proprietary platform that combines small-molecule degraders and Degradation Activating Compounds (DACs) to engage E3 ubiquitin ligases and the ubiquitin–proteasome system, Nurix aims to selectively remove disease-causing proteins. The company advances multiple discovery and development programs and collaborates with partners to translate its platform into novel therapies. Their mission, "Medicines to Outmatch Disease," guides efforts to create differentiated, targeted treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nurix.
Nurix Therapeutics: Why This Company Could Double In Value? (NASDAQ:NRIX)
1 month ago
Associate Director, GMP Quality Assurance
Revolution Medicines
Technical Manager – Peptide Development
Perspective Therapeutics
Senior Director, GMP Quality Assurance
Beeline Medicines
Director, CMC Product Development – Small Molecule
Beeline Medicines
Associate Director, CMC Product Development – Small Molecule
Beeline Medicines
Analytical Development, Senior Manager
Intuitive